Skip to main content

Clinical

To overcome setbacks in combating the nation’s opioid crisis caused by the COVID-19 pandemic, policies and resources will need to be crafted in ways that address systemic inequities that have exacerbated challenges for specific populations, Acting Assistant Secretary for Mental Health and Substance Use Tom Coderre told Rx Drug Abuse & Heroin Summit attendees on Wednesday evening.
Veterans Health Administration officials discuss opioid risk mitigation strategies, keys for aligning stakeholders in their mission, and changes made in light of the COVID-19 pandemic.
The American Society of Addiction Medicine and the American Academy of Addiction Psychiatry are seeking members for a committee to develop clinical practice guidelines for treating stimulant use disorder.
A study by Cordant Health Solutions and Northwest Integrated Health found that OUD patients who had been prescribed buprenorphine demonstrated higher retention rates and improved health outcomes when receiving medication at office visits instead of retail pharmacies.
Perspectives
While the national conversation on mental health and addiction treatment remains focused on expanding access, an equal focus on ensuring those services are delivered with high quality is needed.
Back to Top